派博傳思國(guó)際中心

標(biāo)題: Titlebook: Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis; Renato Alberto Sinico,Lo?c Guillevin Book 2020 Springer Nature Switzerl [打印本頁(yè)]

作者: 貪污    時(shí)間: 2025-3-21 17:05
書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis影響因子(影響力)




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis影響因子(影響力)學(xué)科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis網(wǎng)絡(luò)公開度




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis被引頻次




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis被引頻次學(xué)科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis年度引用




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis年度引用學(xué)科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis讀者反饋




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis讀者反饋學(xué)科排名





作者: Nerve-Block    時(shí)間: 2025-3-21 23:50

作者: intrigue    時(shí)間: 2025-3-22 02:43
Introduction: Nomenclature and Classificationation and diagnosis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Physicians and scientists have made remarkable advances in the classification and diagnosis of vasculitides since the seminal observations in the 1800s; however, validated and widely applied classification
作者: Popcorn    時(shí)間: 2025-3-22 07:43
Genetics of ANCA-Associated Vasculitis in complex susceptibility loci and disease mechanisms. Finally, we discuss the limitations of current methods and the challenges that we still have to approach in order to translate genomic and epigenomic data into clinical practice.
作者: 衰弱的心    時(shí)間: 2025-3-22 09:49
ANCA: Methods and Clinical Significanceoassays for PR3-ANCA and MPO-ANCA. New guidelines for ANCA testing have been developed based on a recent European multicenter study, and according to the revised 2017 international consensus recommendations, testing for ANCA in small-vessel vasculitis can be done by PR3-ANCA and MPO-ANCA immunoassay
作者: Frisky    時(shí)間: 2025-3-22 15:49

作者: Interregnum    時(shí)間: 2025-3-22 20:30

作者: Nonflammable    時(shí)間: 2025-3-23 01:08
Granulomatosis with Polyangiitisccurring within 1?year of the first symptoms. With current treatments, which include first an induction phase, based on the combination of corticosteroids and an immunosuppressant, then a maintenance treatment phase, remission can be achieved in more than 80% of cases. However, the relapse-free surv
作者: UTTER    時(shí)間: 2025-3-23 03:44
Microscopic Polyangiitiseart disease..Anti-neutrophil cytoplasmic antibodies, usually P-ANCA/MPO-ANCA, are detected in up to 80–90% of patients with active MPA..Untreated MPA has an unfavorable course and is associated with increased mortality and end-stage renal disease (ESRD). Factors independently related to death are t
作者: 主講人    時(shí)間: 2025-3-23 05:50

作者: Heterodoxy    時(shí)間: 2025-3-23 12:45

作者: Orgasm    時(shí)間: 2025-3-23 17:57

作者: plasma-cells    時(shí)間: 2025-3-23 20:35
Peripheral Nervous System Involvementon of patients with suspected vasculitic neuropathy usually includes EMG, laboratory studies, and nerve/muscle biopsy. In patients lacking definite vasculitis in nerve biopsy, clinically probable vasculitic neuropathy can be diagnosed by recourse to supportive clinicopathologic findings. Vasculitic
作者: 有危險(xiǎn)    時(shí)間: 2025-3-24 00:05

作者: Compassionate    時(shí)間: 2025-3-24 04:39

作者: poliosis    時(shí)間: 2025-3-24 09:53
Miscellaneous Organ Involvement in ANCA-Associated Vasculitisand may range from mild to life-threatening complications, even requiring surgery. A small number of granulomatosis with polyangiitis (GPA) male patients develop prostatitis as the most common urogenital manifestation, while therapy based on cyclophosphamide may cause hemorrhagic cystitis and urothe
作者: 變異    時(shí)間: 2025-3-24 11:47
Prognosis and Outcomes of ANCA-Associated Vasculitisham Vasculitis Activity Score (BVAS) and its subsequent modifications are routinely used for activity assessment, while the vasculitis damage index (VDI) has been developed to assess all-cause damage after the vasculitis diagnosis. Disease-specific quality-of-life tools are in development and approa
作者: 前面    時(shí)間: 2025-3-24 17:32

作者: Ligneous    時(shí)間: 2025-3-24 19:21

作者: headway    時(shí)間: 2025-3-25 00:26

作者: 我沒有命令    時(shí)間: 2025-3-25 05:38
https://doi.org/10.1007/978-3-642-91970-1oassays for PR3-ANCA and MPO-ANCA. New guidelines for ANCA testing have been developed based on a recent European multicenter study, and according to the revised 2017 international consensus recommendations, testing for ANCA in small-vessel vasculitis can be done by PR3-ANCA and MPO-ANCA immunoassay
作者: Budget    時(shí)間: 2025-3-25 07:29

作者: 無法治愈    時(shí)間: 2025-3-25 15:12

作者: CLAM    時(shí)間: 2025-3-25 16:41
Kraftanlagen mit innerer Verbrennung,ccurring within 1?year of the first symptoms. With current treatments, which include first an induction phase, based on the combination of corticosteroids and an immunosuppressant, then a maintenance treatment phase, remission can be achieved in more than 80% of cases. However, the relapse-free surv
作者: 有角    時(shí)間: 2025-3-25 23:45
,K?lteanlagen und W?rmepumpenanlagen,eart disease..Anti-neutrophil cytoplasmic antibodies, usually P-ANCA/MPO-ANCA, are detected in up to 80–90% of patients with active MPA..Untreated MPA has an unfavorable course and is associated with increased mortality and end-stage renal disease (ESRD). Factors independently related to death are t
作者: 和音    時(shí)間: 2025-3-26 01:17

作者: 小臼    時(shí)間: 2025-3-26 07:51

作者: 神刊    時(shí)間: 2025-3-26 08:44

作者: engrossed    時(shí)間: 2025-3-26 15:59
Einführung in die Maschinenelementeon of patients with suspected vasculitic neuropathy usually includes EMG, laboratory studies, and nerve/muscle biopsy. In patients lacking definite vasculitis in nerve biopsy, clinically probable vasculitic neuropathy can be diagnosed by recourse to supportive clinicopathologic findings. Vasculitic
作者: 責(zé)怪    時(shí)間: 2025-3-26 19:54
Einführung in die Maschinenelemente in half of the patients given the involvement of small-sized vessels, which are beyond the detection capacity of the procedure. Biopsy is rarely performed in clinical practice but can help diagnosis. A complete workup including infective and autoimmune serologies (especially ANCA dosage) as well as
作者: gustation    時(shí)間: 2025-3-26 23:09

作者: 短程旅游    時(shí)間: 2025-3-27 04:58

作者: Aviary    時(shí)間: 2025-3-27 07:34

作者: 抑制    時(shí)間: 2025-3-27 09:26

作者: Arbitrary    時(shí)間: 2025-3-27 15:41
Springer Nature Switzerland AG 2020
作者: 無動(dòng)于衷    時(shí)間: 2025-3-27 20:50
Einführung in die Markscheidekundeiple patterns of injury, diverse known etiologies and pathogenic mechanisms, absence of known etiologies and pathogenic mechanisms in some forms of vasculitis, and the myriad overlapping and nonspecific signs and symptoms caused by vasculitides. The goals of nomenclature, classification, and diagnos
作者: Ataxia    時(shí)間: 2025-3-27 23:51

作者: Memorial    時(shí)間: 2025-3-28 04:28
Einführung in die Markscheidekundeher MPO or PR3 proteins play a key role. Molecular mimicry through bacterial antigens, the presentation of peptides complementary to PR3, and the presentation of MPO and PR3 proteins through NETs can induce the production of anti-MPO or anti-PR3 autoantibodies, especially in the context of TH17/Treg
作者: 十字架    時(shí)間: 2025-3-28 08:27
https://doi.org/10.1007/978-3-642-91970-1culitis (AAV). Such autoantibodies may also be detected in a wide range of inflammatory and infectious diseases leading to a critical reappraisal in the diagnostic significance. ANCA-associated vasculitides are a heterogeneous group of rare syndromes characterized by necrotizing inflammation of smal
作者: Goblet-Cells    時(shí)間: 2025-3-28 13:33
https://doi.org/10.1007/978-3-642-91970-1A major factor in defining optimal therapy and in measuring the success or failure of therapy is careful evaluation of each case. There are no simple measurements to define disease activity or response to treatment. A combination of a structured clinical assessment together with key laboratory measu
作者: VERT    時(shí)間: 2025-3-28 17:17

作者: 信徒    時(shí)間: 2025-3-28 20:45

作者: 共同給與    時(shí)間: 2025-3-29 01:26

作者: 愚笨    時(shí)間: 2025-3-29 05:57

作者: expeditious    時(shí)間: 2025-3-29 07:36

作者: figurine    時(shí)間: 2025-3-29 15:19
https://doi.org/10.1007/978-3-663-05920-2ly characterized by a pauci-immune necrotizing and crescentic glomerulonephritis with a very rapid decline of renal function (rapidly progressive glomerulonephritis)..Even though there are no qualitative differences in glomerular lesions in patients with granulomatosis with polyangiitis (GPA) or mic
作者: 熒光    時(shí)間: 2025-3-29 15:49
Einführung in die Maschinenelementeculitic neuropathy) but more frequently evolves in the setting of a systemic vasculitis. Polyarteritis nodosa, anti-neutrophil antibody-associated vasculitides (especially microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis), rheumatoid vasculitis, and cryoglobulinemic vasculi
作者: floodgate    時(shí)間: 2025-3-29 20:10

作者: ICLE    時(shí)間: 2025-3-30 01:15

作者: 激勵(lì)    時(shí)間: 2025-3-30 05:59
Wolfgang G?pel,Christiane Zieglerscellaneous organ manifestations including the involvement of cardiovascular and musculoskeletal system, gastrointestinal and urogenital tract, occur in only a minority of patients but may have a profound impact on morbidity and mortality. As an example, cardiac involvement, including subclinical fo
作者: MAOIS    時(shí)間: 2025-3-30 11:56

作者: Prostatism    時(shí)間: 2025-3-30 12:38
https://doi.org/10.1007/3-540-35122-1g ANCA in >30–90% of the affected patients. Granulomatosis with polyangiitis (GPA, formerly Wegener’s granulomatosis), eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg–Strauss syndrome), and microscopic polyangiitis (MPA) are AAVs [1]. Renal-limited vasculitis, another AAV, is a b
作者: 帶來    時(shí)間: 2025-3-30 19:14
Renato Alberto Sinico,Lo?c GuillevinWritten by well-known experts in the field.Presents updates with regard to rare disorders.Addresses to specialists in different diseases
作者: 多余    時(shí)間: 2025-3-31 00:32
Rare Diseases of the Immune Systemhttp://image.papertrans.cn/a/image/158348.jpg
作者: FAZE    時(shí)間: 2025-3-31 01:57

作者: Badger    時(shí)間: 2025-3-31 06:13
Introduction: Nomenclature and Classificationiple patterns of injury, diverse known etiologies and pathogenic mechanisms, absence of known etiologies and pathogenic mechanisms in some forms of vasculitis, and the myriad overlapping and nonspecific signs and symptoms caused by vasculitides. The goals of nomenclature, classification, and diagnos
作者: 或者發(fā)神韻    時(shí)間: 2025-3-31 10:25

作者: MAOIS    時(shí)間: 2025-3-31 14:27
Etiopathogenesis of ANCA-Associated Vasculitisher MPO or PR3 proteins play a key role. Molecular mimicry through bacterial antigens, the presentation of peptides complementary to PR3, and the presentation of MPO and PR3 proteins through NETs can induce the production of anti-MPO or anti-PR3 autoantibodies, especially in the context of TH17/Treg
作者: 良心    時(shí)間: 2025-3-31 19:56
ANCA: Methods and Clinical Significanceculitis (AAV). Such autoantibodies may also be detected in a wide range of inflammatory and infectious diseases leading to a critical reappraisal in the diagnostic significance. ANCA-associated vasculitides are a heterogeneous group of rare syndromes characterized by necrotizing inflammation of smal
作者: ensemble    時(shí)間: 2025-4-1 00:52
Activity and DamageA major factor in defining optimal therapy and in measuring the success or failure of therapy is careful evaluation of each case. There are no simple measurements to define disease activity or response to treatment. A combination of a structured clinical assessment together with key laboratory measu
作者: ENDOW    時(shí)間: 2025-4-1 05:38





歡迎光臨 派博傳思國(guó)際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
页游| 孙吴县| 榆林市| 万宁市| 威宁| 广元市| 桦川县| 宾川县| 嵊州市| 子洲县| 定边县| 津南区| 奉节县| 手游| 藁城市| 黎城县| 来安县| 吉木乃县| 桐城市| 衡阳市| 犍为县| 台南市| 博客| 天津市| 穆棱市| 海丰县| 安乡县| 临桂县| 仙桃市| 富民县| 巴塘县| 南溪县| 桦川县| 衡水市| 宽城| 甘德县| 比如县| 西和县| 永胜县| 泌阳县| 建宁县|